全文获取类型
收费全文 | 2672篇 |
免费 | 146篇 |
国内免费 | 223篇 |
出版年
2024年 | 2篇 |
2023年 | 21篇 |
2022年 | 25篇 |
2021年 | 44篇 |
2020年 | 42篇 |
2019年 | 72篇 |
2018年 | 54篇 |
2017年 | 57篇 |
2016年 | 69篇 |
2015年 | 84篇 |
2014年 | 121篇 |
2013年 | 153篇 |
2012年 | 78篇 |
2011年 | 129篇 |
2010年 | 109篇 |
2009年 | 170篇 |
2008年 | 156篇 |
2007年 | 205篇 |
2006年 | 201篇 |
2005年 | 177篇 |
2004年 | 156篇 |
2003年 | 156篇 |
2002年 | 148篇 |
2001年 | 97篇 |
2000年 | 83篇 |
1999年 | 80篇 |
1998年 | 47篇 |
1997年 | 56篇 |
1996年 | 33篇 |
1995年 | 36篇 |
1994年 | 15篇 |
1993年 | 14篇 |
1992年 | 11篇 |
1991年 | 15篇 |
1990年 | 11篇 |
1989年 | 7篇 |
1988年 | 8篇 |
1987年 | 11篇 |
1986年 | 7篇 |
1985年 | 5篇 |
1984年 | 11篇 |
1983年 | 19篇 |
1982年 | 15篇 |
1981年 | 7篇 |
1980年 | 6篇 |
1979年 | 8篇 |
1978年 | 2篇 |
1977年 | 3篇 |
1974年 | 2篇 |
1967年 | 1篇 |
排序方式: 共有3041条查询结果,搜索用时 609 毫秒
41.
42.
43.
44.
Gary W. Harrison 《Journal of mathematical biology》1980,10(1):65-77
Summary The time derivatives of prey and predator populations are assumed to satisfy a set of inequalities, instead of a precise differential equation, reflecting an uncertain environmental and/or lack of knowledge by the modeler. A system of differential equations is found whose solution gives the boundary of a persistent set, which is positive flow invariant for any system satisfying the inequalities. Conditions are given for the persistent set to be bounded away from both axes, which show that resonance effects cannot drive either predator or prey to extinction if that does not happen for an autonomous system satisfying the inequalities. In general predator-prey systems are more persistent when there is strong asymptotic stability, when there is correlation between prey and predator dynamics, when the effect of perturbations is density dependent, and are more persistent under perturbations of the prey than of the predator. 相似文献
45.
46.
Phage display, one of today’s fundamental drug discovery technologies, allows identification of a broad range of biological drugs, including peptides, antibodies and other proteins, with the ability to tailor critical characteristics such as potency, specificity and cross-species binding. Further, unlike in vivo technologies, generating phage display-derived antibodies is not restricted by immunological tolerance. Although more than 20 phage display-derived antibody and peptides are currently in late-stage clinical trials or approved, there is little literature addressing the specific challenges and successes in the clinical development of phage-derived drugs. This review uses case studies, from candidate identification through clinical development, to illustrate the utility of phage display as a drug discovery tool, and offers a perspective for future developments of phage display technology. 相似文献
47.
《MABS-AUSTIN》2013,5(6):1608-1620
Anti-cytokine autoantibodies have been widely reported to be present in human plasma, both in healthy subjects and in patients with underlying autoimmune conditions, such as autoimmune polyendocrinopathy candidiasis ectodermal dystrophy (APECED) or thymic epithelial neoplasms. While often asymptomatic, they can cause or facilitate a wide range of diseases including opportunistic infections. The potential therapeutic value of specific neutralizing anti-cytokine autoantibodies has not been thoroughly investigated. Here we used mammalian cell display to isolate IL17A-specific antibodies from a thymoma patient with proven high-titer autoantibodies against the same. We identified 3 distinct clonotypes that efficiently neutralized IL17A in a cell-based in vitro assay. Their potencies were comparable to those of known neutralizing antibodies, including 2, AIN457 (secukinumab) and ixekizumab that are currently in clinical development for the treatment of various inflammatory disorders. These data clearly demonstrate that the human autoantibody repertoire can be mined for antibodies with high therapeutic potential for clinical development. 相似文献
48.
Shuhao Li Yang Zou Dongping Zhao Yuqing Yin Jingyi Song Ningning He Huadong Liu Dongmeng Qian Lei Li Haiming Huang 《Protein science : a publication of the Protein Society》2021,30(3):558
Protein engineering through directed evolution is an effective way to obtain proteins with novel functions with the potential applications as tools for diagnosis or therapeutics. Many natural proteins have undergone directed evolution in vitro in the test tubes in the laboratories worldwide, resulting in the numerous protein variants with novel or enhanced functions. we constructed here an SH2 variant library by randomizing 8 variable residues in its phosphotyrosine (pTyr) binding pocket. Selection of this library by a pTyr peptide led to the identification of SH2 variants with enhanced affinities measured by EC50. Fluorescent polarization was then applied to quantify the binding affinities of the newly identified SH2 variants. As a result, three SH2 variants, named V3, V13 and V24, have comparable binding affinities with the previously identified SH2 triple‐mutant superbinder. Biolayer Interferometry assay was employed to disclose the kinetics of the binding of these SH2 superbinders to the phosphotyrosine peptide. The results indicated that all the SH2 superbinders have two‐orders increase of the dissociation rate when binding the pTyr peptide while there was no significant change in their associate rates. Intriguingly, though binding the pTyr peptide with comparable affinity with other SH2 superbinders, the V3 does not bind to the sTyr peptide. However, variant V13 and V24 have cross‐reactivity with both pTyr and sTyr peptides. The newly identified superbinders could be utilized as tools for the identification of pTyr‐containing proteins from tissues under different physiological or pathophysiological conditions and may have the potential in the therapeutics. 相似文献
49.
Beatris Mastelic Nathalie Garçon Giuseppe Del Giudice Hana Golding Marion Gruber Pieter Neels Bernard Fritzell 《Biologicals》2013,41(6):458-468
Vaccination represents one of the greatest public health triumphs; in part due to the effect of adjuvants that have been included in vaccine preparations to boost the immune responses through different mechanisms. Although a variety of novel adjuvants have been under development, only a limited number have been approved by regulatory authorities for human vaccines. This report reflects the conclusions of a group of scientists from academia, regulatory agencies and industry who attended a conference on the current state of the art in the adjuvant field. Held at the U.S. Pharmacopeial Convention (USP) in Rockville, Maryland, USA, from 18 to 19 April 2013 and organized by the International Association for Biologicals (IABS), the conference focused particularly on the future development of effective adjuvants and adjuvanted vaccines and on overcoming major hurdles, such as safety and immunogenicity assessment, as well as regulatory scrutiny. More information on the conference output can be found on the IABS website, http://www.iabs.org/. 相似文献
50.
J. Sundnes G.T. Lines K.A. Mardal A. Tveito 《Computer methods in biomechanics and biomedical engineering》2013,16(6):397-409
The electrical activity of the heart may be modeled with a system of partial differential equations (PDEs) known as the bidomain model. Computer simulations based on these equations may become a helpful tool to understand the relationship between changes in the electrical field and various heart diseases. Because of the rapid variations in the electrical field, sufficiently accurate simulations require a fine-scale discretization of the equations. For realistic geometries this leads to a large number of grid points and consequently large linear systems to be solved for each time step. In this paper, we present a fully coupled discretization of the bidomain model, leading to a block structured linear system. We take advantage of the block structure to construct an efficient preconditioner for the linear system, by combining multigrid with an operator splitting technique. 相似文献